Your browser doesn't support javascript.
loading
Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest.
Han, Bingjie; Sun, Yuanyuan; Zhang, Xiaofen; Yue, Ping; Tian, Meiling; Yan, Dan; Yin, Fanxiang; Qin, Bo; Zhao, Yi.
Afiliación
  • Han B; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Sun Y; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang X; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yue P; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Tian M; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yan D; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yin F; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Qin B; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhao Y; Department of Translational Medical Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Pharmacol ; 13: 942261, 2022.
Article en En | MEDLINE | ID: mdl-35910374
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China